loader2
Login Open ICICI 3-in-1 Account

Medplus Health Services Results: Latest Quarterly Results & Analysis

Open Free Trading Account Online with ICICIDIRECT
+91
Medplus Health Services Ltd. 04 Aug 2025 11:24 AM

Q1FY26 Quarterly Result Announced for Medplus Health Services Ltd.

Healthcare Supplies company Medplus Health Services announced Q1FY26 results

  • Revenue: Rs 15,426 million compaed to Rs 538 million increase over Q1FY25 3.6% YoY.
  • Operating EBITDA: Rs 690 million.
  • Operating EBITDA margin: 4.6% in Pharmacy (decreased by 60 bps QoQ).
  • Gross Margin: Rs 4,029 million, 26.1% GM%, decreased by 40 bps QoQ and increased by 400 bps YoY.
  • 101 Store Net Additions
  • Operating Cash Flow: Rs 1,872 million, 257.2% OCF/ Operating EBITDA: Rs 5,549 million closing cash & bank balance.

Result PDF

Healthcare Supplies company Medplus Health Services announced Q1FY25 results:

  • Revenue: Rs 14,888 million, Rs 2,045m increase over Q1FY24 15.9% YoY
  • Gross Margin: Rs 3,293 million, 22.1% gross margin (-0.5% QoQ)
  • Pharmacy Operating EBITDA: Rs 432 million. 3.0% Operating EBITDA margin in Pharmacy (decreased by 100 bps QoQ)
  • Operating Cash Flow: Rs 585 million, 134.7% OCF/ Operating EBITDA

Result PDF

Healthcare Supplies company Medplus Health Services announced Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Revenue: Rs 56,249 million Increase by 23.4% vs FY23, 14.3% private label ( 0.6% vs FY23)
  • Gross Margin: Rs 12,332 million, 21.9% gross margin
  • 585 Store Net Additions
  • 670 gross additions and 333 net additions beyond Tier-One
  • 4,407 stores as on 31-Mar-24
  • 20.5% revenue growth for stores opened more than 12 months vs. FY23
  • 9.2% Store Level EBITDA margin
  • Operating EBITDA: Rs 1,748 million
  • 3.1% Operating EBITDA margin
  • Pharmacy Operating EBITDA Rs 1,882 million
  • Operating Cash Flow: Rs 1,437 million
  • 82.2% OCF/ Operating EBITDA
  • closing cash balance: Rs 1,702 million

FY24 Financial Highlights:

  • Revenue: Rs 14,905 million, Rs 2,375 million increase over Q4FY23, 19.0% YoY, and Rs 490 million increase over Q3FY24. 3.4% QoQ
  • 1.1% increase in private label over Q4FY23
  • Gross Margin: Rs 3,366 million, 22.6% gross margin (0.5% QoQ)
  • 174 Store Net Additions and 199 gross additions
  • 100 net store additions beyond Tier-One
  • 4,407 stores as on 31-Mar-24
  • 11.7% revenue growth for stores opened for more than 12 months over Q4FY23
  • 10.3% Store Level EBITDA margin
  • 52.2% Store Level Operating ROCE
  • Pharmacy Operating EBITDA: Rs 593 million
  • 4.0% Operating EBITDA margin in Pharmacy (increased by 40 bps QoQ)
  • Company Operating EBITDA: Rs 581 million
  • Operating Cash Flow: Rs 406 million
  • 69.8% OCF/ Operating EBITDA
  • closing cash balance: Rs 1,702 million

Result PDF

Healthcare supplies firm Medplus Health Services announced Q4FY23 results:

  • Revenue growth of 5.2% over previous quarter and 29% over Q4 FY22.
  • Gross addition of 284 stores in Q4 FY23.
  • Gross margin of 22% in Q4 FY23.
  • EBITDA margin of 3.6% in Q4 FY23, increased by 10 bps over previous quarter.
  • Gross store additions in Q4 FY23 of 284 stores.

 

 

Result PDF

Medplus Health Services announced Q3FY23 results:

  • Consolidated Q3FY23:
    • Revenue growth of 6.2% over the previous quarter and 27.5% over the previous year.
    • Gross margin of 21.7% in Q3FY23.
    • EBITDA margin of 3.5% in Q3FY23, increased by 50 bps over previous quarter.
    • Gross store additions in Q3FY23 of 246 stores. Our stores greater than 12 months have delivered a strong store level EBITDA margin of 10% and overall EBITDA margin of 4.9%, thereby maintaining the trajectory of store maturity.

Result PDF

Medplus Health Services announced Q2FY23 results:

  • Q2FY23:
    • Consolidated revenue has gone up by 21.2% over the previous year
    • Highest-ever store expansion of 362 new stores launched in Q2FY23
    • Our increasing share of private label sales, 13.9% in QFY23
    • Our stores older than 12 months have delivered strong Store Level EBITDA margins of 9.7% and Corporate Level EBITDA margins of 4.6%, thereby maintaining the trajectory of store maturity.

Result PDF

Medplus Health Services announced Q4FY22 results:

  • Q4FY22:
    • 271 store net additions
    • Revenue of Rs 966 Crore, YoY growth of 19.9%
    • Share of Private Label 13.0%
    • Pharmacy Operating EBITDA of Rs 39.5 Crore
  • FY22:
    • 667 store net additions in full year FY22
    • Revenue of Rs 3779 Crore, YoY growth of 23.1% (FY22 over FY21)
    • Share of Private Label 12.7% in full year FY22
    • Pharmacy operating EBITDA of Rs 186 Crore in full year FY22

“In Q4FY22 we opened 288 new stores. This is a new record for MedPlus and is proof of our operational and supply chain capabilities. We will continue our growth plans in the coming quarters. Our stores greater than 12 months have delivered a store level EBITDA margin of 10.3%, thereby maintaining the trajectory of store maturity. In March we launched our first full-service Diagnostic Center and have received strong adoption from our existing and new customers.” - Gangadi Madhukar Reddy, MD & CEO, MedPlus Health Services

Result PDF

Disclaimer – I ICICI Securities Ltd. ( I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is acting as a distributor to solicit bond related products. All disputes with respect to the distribution activity, would not have access to Exchange investor redressal forum or Arbitration mechanism. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein mentioned are solely for informational and educational purpose.
Download App

Download Our App

Play Store App Store
market app